PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home »

Psychiatric Times. Vol. 24 No. 6
Pages: 1  2  3  
Next
 

Quality of Life in Patients With Bipolar Disorder: Defining and Measuring Goals

By Greg Murray, PhD and Erin E. Michalak, PhD | May 1, 2007
Dr Murray is senior lecturer and clinical psychologist in the department of Life and Social Sciences at Swinburne University of Technology in Australia. Dr Michalak is assistant professor at the Mood Disorders Centre at the University of British Columbia in Vancouver. They report that they have no conflicts of interest concerning the subject matter of this article.

Bipolar disorder (BD) is a complex and heterogeneous condition characterized by a variety of symptoms and marked variability in disease course. A patient with BD can experience episodes of depression, hypomania, mania, or psychosis and, indeed, can experience a mixture of emotional states or cycle rapidly between them. In fact, recent research has highlighted the prevalence of marked subsyndromal features between episodes,1 but despite currently available treatments, BD remains a chronic relapsing condition.2

Given the symptom profile of BD, it is not surprising that the diagnosis is typically associated with significant disability and impaired functioning. According to World Health Organization (WHO) estimates, BD was the 6th leading cause of disability worldwide among young adults at the turn of the century.3 For example, if BD develops in a woman at the age of 25, she may lose 9 years in life expectancy (because of cardiovascular and other medical problems), 14 years of productivity, and 12 years of good health.4 Disturbingly, the lifetime suicide rates of patients with BD (treated or not) may be as high as 15%.5

Beyond symptoms to quality of life
While outcomes in patients with BD have traditionally been assessed as objectively measured clinicalinformation (such as relapse rates, number of hospitalizations, or symptom reduction as rated by a clinician-rated scale), a number of arguments suggest the need for the addition of functional and quality-of-life (QOL) measures.6-8 It has been observed clinically, for example, that some patients appear to function poorly despite relatively few symptoms, while others function well in the context of relatively severe symptoms.7 Likewise, there is evidence for a disjunction between symptom change and QOL change in response to treatment, with the latter typically lagging substantially behind the former.9 Finally, as discussed later in this article, patients themselves attend to more than symptoms when assessing the success of their treatment, and it would be reasonable to expect that the treatment alliance would benefit when clinicians share this more holistic viewpoint.6

The movement toward a broader set of outcome measures in BD is consistent with a change in the zeitgeist of BD research in the past decade. Mirroring the developments that occurred in schizophrenia research a decade earlier,10 biopsychosocial models of BD have recently been proposed,11-13 and a number of adjunctive psychosocial treatments for BD have been found efficacious.14,15 Researchers from this contemporary tradition have called for expanded targets for therapy7 and, hence, an expanded range of outcome mea-surements in BD. Indeed, it may be in the area of functional outcomes that psychosocial interventions make their strongest contribution.16 As asserted by Harvey,17 for example: "recovery should not be defined merely by symptomatic remission or even syndromal remission; rather, recovery should include symptomatic recovery, syndromal recovery, functional recovery, and a return to an acceptable quality of life for the patient."

Although the terms "QOL" and "functioning" are often used interchangeably, it may be useful to distinguish between them. Functioning is typically clinician-assessed and refers to objective function in a variety of behavioral domains. In contrast, QOL is commonly understood as a subjective indicator of patient well-being. The WHO has described QOL as the "individuals' perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards, and concerns."18 Although the domains encompassed by QOL and functioning may overlap (eg, social, occupational, and independent living), the former are characterized by an emphasis on subjective assessment of satisfaction. This article focuses on the subjective assessments of QOL in BD. Given the limited evidence base, our review will not distinguish between a broad conceptualization of QOL and health-related quality of life (HRQOL), with the latter referring specifically to those aspects of life that are impacted by health or ill health.

Pages: 1  2  3  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





  • Michalak EE, Murray G, Levitt AJ, et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the Can-SAD study. Psychol Med. 2006;37:1-10.
  • Scott J, Colom F,Vieta E.A meta-analysis of relapse rates with adjunctive psychological therapies compared to usual psychiatric treatment for bipolar disorders. Int J Neuropsychopharmacol. 2007;10:123-129.


 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Developmental Psychopathology Comes of Age
  • The Moral Struggles of Practicing Psychiatrists
  • Grief and Depression: The Sages Knew the Difference
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Developmental Psychopathology Comes of Age
  • Psychiatry and the Myth of “Medicalization”
  • An Update on ADHD
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • Ethical and Legal Issues in Geriatric Psychiatry
  • Eco-Psychiatry: Why We Need to Keep the Environment in Mind
  • DSM-5: Where Do We Go From Here?
  • Suicidal Behavior: A Separate Diagnosis
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • Diagnosis and its Discontents: The DSM Debate Continues
  • Lamotrigine for Major Depressive Disorder Is Inappropriate
  • Psychiatry and the Myth of “Medicalization”
  • Parity Laws: Powerful Weapon—or Pipe Dream?
  • The Moral Struggles of Practicing Psychiatrists
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • NIMH vs DSM 5: No One Wins, Patients Lose
Click here to subscribe to our newsletter
 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry
 
SearchMedica SEARCH RESULT

Find peer-reviewed literature and websites for practicing medical professionals

CME on Display
Evidence on Display
Guidelines on Display
Patient Education on Display
Clinical Trials on Display
Practical Articles on Display
Research and Reviews on Display
All "Display" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy